A Trial of Neoadjuvant mFOLFOXIRI Versus CRT in the EMVI Positive LARC
Clinical trial NCT04423965 · UNKNOWN
Trial details
- NCT number
- NCT04423965
- Sponsor
- First Affiliated Hospital of Zhejiang University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-12
- Primary completion
- 2022-05-01
- Enrollment
- 220
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.